linaclotide 0.145 MG Oral Capsule [Linzess]
RxNorm concept 1307415, branded drug (sbd). Prescribable name: Linzess 145 MCG Oral Capsule.
- RxCUI
- 1307415
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1307415 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Linzess 0.145 MG Oral Capsule; Linzess 145 MCG Oral Capsule
Related concepts
- linaclotide 0.145 MG (SCDC, consists of)
- linaclotide 0.145 MG [Linzess] (SBDC, consists of)
- Oral Capsule (DF, has dose form)
- Linzess (BN, has ingredient)
- linaclotide 0.145 MG Oral Capsule (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1307415 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1307415 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1307415. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.